“Introducing a New Disinfection Technology Against C. diff.”
Jordan Bastian (Speaker) Infection Preventionist, CloroxPro Clinical and Scientific Affairs, Clorox Company
"Ibezapolstat Update: Can Emerging Microbiome Findings Contribute to CDI Anti-Recurrence Effect?"
Kevin Garey (Speaker) Chair of the Department of Pharmacy Practice and Translational Research and Professor of Pharmacy Practice, University of Houston College of Pharmacy "More Than a CDI: The Revolving Door and a Ray Of Hope."
Kathy Bischoff (Speaker) Coordinator, VHA Program, C Diff Foundation
Sponsored by
ACURX
|